Clinical Trials Arena on MSN8d
Funding drought: how can biotech and biopharma keep trials running?
Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...
Zacks Research Issues Positive Forecast for BMRN Earnings
Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for BioMarin Pharmaceutical in a research note issued on Wednesday, March 12th. Zacks Research analyst S. Ganoria ...
ETF Daily News8d
HC Wainwright Issues Pessimistic Forecast for Unity Biotechnology (NASDAQ:UBX) Stock Price
Unity Biotechnology (NASDAQ:UBX – Get Free Report) had its target price decreased by stock analysts at HC Wainwright from $8.00 to $4.00 in a report issued on Monday,Benzinga reports.